These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12187742)

  • 1. [H. pylori infection in the aged].
    Oda H; Asaka M
    Nihon Rinsho; 2002 Aug; 60(8):1504-7. PubMed ID: 12187742
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenesis of Helicobacter pylori-negative peptic ulcer].
    Takagi A; Kobayashi K; Deguchi R
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():613-6. PubMed ID: 16363612
    [No Abstract]   [Full Text] [Related]  

  • 4. Helicobacter pylori and its involvement in gastritis and peptic ulcer formation.
    Konturek SJ; Konturek PC; Konturek JW; Plonka M; Czesnikiewicz-Guzik M; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():29-50. PubMed ID: 17033104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peptic ulcer and environmental factor: with special focus on Helicobacter pylori infection].
    Tatemichi M; Tsugane S
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():179-83. PubMed ID: 11979773
    [No Abstract]   [Full Text] [Related]  

  • 6. [H. pylori infection].
    Asaka M; Kato M
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():303-10. PubMed ID: 11838131
    [No Abstract]   [Full Text] [Related]  

  • 7. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Legido J; García-Sanz I; Pajares JM
    Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of H. pylori infection].
    Fukuda Y; Tomita T; Sakagami T; Shimoyama T
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():40-8. PubMed ID: 11979814
    [No Abstract]   [Full Text] [Related]  

  • 9. Helicobacter pylori and non-steroidal anti-inflammatory drugs: ulcers and bleeding ulcers.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):116-8. PubMed ID: 10363195
    [No Abstract]   [Full Text] [Related]  

  • 10. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection.
    Pérez-Aisa MA; Del Pino D; Siles M; Lanas A
    Aliment Pharmacol Ther; 2005 Jan; 21(1):65-72. PubMed ID: 15644047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Helicobacter pylori infection and endoscopic gastric findings among a young Japanese population].
    Shimatani T; Tazuma S; Inoue M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():167-71. PubMed ID: 16363525
    [No Abstract]   [Full Text] [Related]  

  • 13. Helicobacter pylori: criminal or innocent bystander?
    Arakawa T; Higuchi K; Fujiwara Y; Tominaga K; Watanabe T; Shiba M; Uchida T; Kuroki T
    J Gastroenterol; 2000; 35 Suppl 12():42-6. PubMed ID: 10779217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
    Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The analysis of the recurrence ulcer after H. pylori eradication].
    Kamada T; Chayama K; Haruma K; Yoshihara M; Ito M; Kitadai Y; Kawamura Y
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():501-5. PubMed ID: 11979837
    [No Abstract]   [Full Text] [Related]  

  • 16. Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDS or stress?
    Aoyama N; Shinoda Y; Matsushima Y; Shirasaka D; Kinoshita Y; Kasuga M; Chiba T
    J Gastroenterol; 2000; 35 Suppl 12():33-7. PubMed ID: 10779215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathophysiology of ulcer disease].
    Beglinger C
    Ther Umsch; 1992 Nov; 49(11):743-8. PubMed ID: 1475770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology and risk factors of gastroduodenal ulcer].
    Kreiss C; Blum AL
    Chirurg; 1996 Jan; 67(1):7-13. PubMed ID: 8851669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present state and future view of the indications for H. pyloni eradication therapy].
    Takahashi S; Tanaka A; Sugano H
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():23-6. PubMed ID: 16363498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.